Annual Total Expenses
$114.51 M
+$34.34 M+42.83%
December 31, 2023
Summary
- As of February 7, 2025, TCRX annual total expenses is $114.51 million, with the most recent change of +$34.34 million (+42.83%) on December 31, 2023.
- During the last 3 years, TCRX annual total expenses has risen by +$87.19 million (+319.16%).
- TCRX annual total expenses is now at all-time high.
Performance
TCRX Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Expenses
$33.67 M
-$979.00 K-2.83%
September 30, 2024
Summary
- As of February 7, 2025, TCRX quarterly total expenses is $33.67 million, with the most recent change of -$979.00 thousand (-2.83%) on September 30, 2024.
- Over the past year, TCRX quarterly total expenses has increased by +$5.04 million (+17.59%).
- TCRX quarterly total expenses is now -2.83% below its all-time high of $34.65 million, reached on June 30, 2024.
Performance
TCRX Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
TCRX Total Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +42.8% | +17.6% |
| 3 y3 years | +319.2% | +17.6% |
| 5 y5 years | +705.8% | +17.6% |
TCRX Total Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +94.8% | -2.8% | +97.4% |
| 5 y | 5-year | at high | +705.8% | -2.8% | +499.6% |
| alltime | all time | at high | +705.8% | -2.8% | +499.6% |
TScan Therapeutics Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $33.67 M(-2.8%) |
| Jun 2024 | - | $34.65 M(+8.5%) |
| Mar 2024 | - | $31.94 M(+11.8%) |
| Dec 2023 | $114.51 M(+42.8%) | $28.57 M(-0.2%) |
| Sep 2023 | - | $28.64 M(+3.2%) |
| Jun 2023 | - | $27.76 M(-6.1%) |
| Mar 2023 | - | $29.55 M(+35.9%) |
| Dec 2022 | $80.17 M | $21.74 M(+9.0%) |
| Sep 2022 | - | $19.94 M(+3.3%) |
| Jun 2022 | - | $19.30 M(+0.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $19.18 M(+12.5%) |
| Dec 2021 | $58.78 M(+115.2%) | $17.06 M(-6.6%) |
| Sep 2021 | - | $18.25 M(+34.9%) |
| Jun 2021 | - | $13.53 M(+36.0%) |
| Mar 2021 | - | $9.95 M(+15.6%) |
| Dec 2020 | $27.32 M(+92.2%) | - |
| Dec 2020 | - | $8.61 M(+15.3%) |
| Sep 2020 | - | $7.46 M(+32.9%) |
| Jun 2020 | - | $5.62 M(-0.4%) |
| Mar 2020 | - | $5.64 M |
| Dec 2019 | $14.21 M | - |
FAQ
- What is TScan Therapeutics annual total expenses?
- What is the all time high annual total expenses for TScan Therapeutics?
- What is TScan Therapeutics annual total expenses year-on-year change?
- What is TScan Therapeutics quarterly total expenses?
- What is the all time high quarterly total expenses for TScan Therapeutics?
- What is TScan Therapeutics quarterly total expenses year-on-year change?
What is TScan Therapeutics annual total expenses?
The current annual total expenses of TCRX is $114.51 M
What is the all time high annual total expenses for TScan Therapeutics?
TScan Therapeutics all-time high annual total expenses is $114.51 M
What is TScan Therapeutics annual total expenses year-on-year change?
Over the past year, TCRX annual total expenses has changed by +$34.34 M (+42.83%)
What is TScan Therapeutics quarterly total expenses?
The current quarterly total expenses of TCRX is $33.67 M
What is the all time high quarterly total expenses for TScan Therapeutics?
TScan Therapeutics all-time high quarterly total expenses is $34.65 M
What is TScan Therapeutics quarterly total expenses year-on-year change?
Over the past year, TCRX quarterly total expenses has changed by +$5.04 M (+17.59%)